The Institute for Computational Medicine (ICM) develops and applies new computational methods to reduce the burden of disease: from prevention to diagnosis to treatment to cure; from disease surveillance to design of small molecule therapeutics to genetic medicines and vaccines; and from complex genetic disorders to cancer to critical care medicine.
Latest News
ICM Alumni Kevin Gorman Receives 2026 Paper Award
First author Kevin Gorman and former member of the Taylor/TIRI Lab was selected for the AMIA Clinical Research Informatics Distinguished Paper Award! He presented the conference paper titled "Use of Family Relationships in Commercial Claims Data to Characterize...
Prof. Rachel Karchin, Uncovering how prostate cancer outsmarts treatment
Prostate cancer is heterogeneous: it is a hodgepodge of different kinds of cells, some worse than others. This often means the cancer becomes resistant to therapy – but sometimes, this change opens a new avenue of treatment that wasn’t there before. In a recent...
Dr. Rachel Karchin Inducted into 2025 Class of ISCB Fellows
On July 21, 2025, Rachel Karchin, professor of biomedical engineering, oncology, and computer science and core member of the Institute for Computational Medicine was inducted into the 2025 Class of ISCB fellows. 19 new fellows of the International Society for...



